Skip to content
This research project will quantify, for the first time, the population-level impact of opioid substitution therapy (OST; methadone or buprenorphine) on two important outcomes for opioid dependent prisoners:
This work builds on previous research which examined overall mortality among OST recipients. Although the previous research project successfully determined the association between mortality and OST overall, the research project was unable to examine the two outcomes, stated above, among prisoners because admission, retention and discharge from prison could not be ascertained from the databases examined.
Abstract adapted from National Drug and Alcohol Research Centre
Professor Louisa Degenhardt
National Drug and Alcohol Research Centre
Ph: (02) 9385 0333